SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 301 filers reported holding SEATTLE GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $560,000 | +188.7% | 3,296 | +95.6% | 0.16% | +57.6% |
| Q1 2020 | $194,000 | -75.1% | 1,685 | -75.3% | 0.10% | -35.3% |
| Q4 2019 | $780,000 | +280.5% | 6,825 | +130.6% | 0.15% | +159.3% |
| Q2 2019 | $205,000 | +365.9% | 2,960 | +393.3% | 0.06% | +883.3% |
| Q1 2019 | $44,000 | -56.9% | 600 | -67.2% | 0.01% | -81.8% |
| Q4 2018 | $102,000 | -71.3% | 1,828 | -59.8% | 0.03% | -50.7% |
| Q3 2018 | $356,000 | +128.2% | 4,548 | +89.5% | 0.07% | +86.1% |
| Q2 2018 | $156,000 | +6.8% | 2,400 | -15.0% | 0.04% | 0.0% |
| Q1 2018 | $146,000 | +23.7% | 2,825 | +28.4% | 0.04% | +33.3% |
| Q4 2017 | $118,000 | -91.5% | 2,200 | -91.8% | 0.03% | -86.8% |
| Q2 2017 | $1,387,000 | +400.7% | 26,800 | +211.3% | 0.20% | +117.0% |
| Q4 2014 | $277,000 | – | 8,608 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |